[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Editas Medicine Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Editas Medicine Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

PLx Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PLx Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Agios Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agios Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Wave Life Sciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wave Life Sciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Karyopharm Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Karyopharm Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Phibro Animal Health Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phibro Animal Health Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ionis Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ionis Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Xenon Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenon Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AnaptysBio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnaptysBio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ANI Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ANI Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ProQR Therapeutics NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProQR Therapeutics NV Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Vaxart, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vaxart, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Eagle Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Eagle Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Mediwound Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mediwound Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ascendis Pharma AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ascendis Pharma AS Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Pulmatrix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pulmatrix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Quotient Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quotient Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aratana Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aratana Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cellular Biomedicine Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellular Biomedicine Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cerecor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cerecor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Natera Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natera Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Theravance Biopharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theravance Biopharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Blueprint Medicines Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Blueprint Medicines Corp Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

GlycoMimetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GlycoMimetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Millendo Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Millendo Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bioverativ Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioverativ Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Molecular Templates Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Molecular Templates Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cara Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cara Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Seres Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Seres Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Kalvista Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kalvista Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Stemline Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stemline Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Tetraphase Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tetraphase Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

VBI Vaccines Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VBI Vaccines Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Checkpoint Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Checkpoint Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Intellia Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intellia Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aralez Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aralez Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

MacroGenics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MacroGenics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

NewLink Genetics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NewLink Genetics Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

TherapeuticsMD Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TherapeuticsMD Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Five Prime Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Five Prime Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Endocyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Endocyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Pacira BioSciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pacira BioSciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Sarepta Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sarepta Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

K2M Group Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

K2M Group Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Merus BV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merus BV Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Myos Rens Technology Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Myos Rens Technology Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Portola Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Portola Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BOD Australia Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BOD Australia Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Dimerix Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dimerix Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Noxopharm Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Noxopharm Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers